+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Glaucoma Market by Product Type (Diagnostic & Monitoring Devices, Surgical Devices, Therapeutics), End User (Ambulatory Surgical Centers, Home Care Settings, Hospitals), Distribution Channel, Route Of Administration - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6017423
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Glaucoma care is experiencing accelerating change, with industry leaders and healthcare providers increasingly focused on early detection innovations and strategic integration of emerging technologies. Strategic insight is essential as stakeholder collaboration and tailored solutions become critical for balancing patient outcomes and operational efficiency.

Market Snapshot: Glaucoma Market Performance

The glaucoma market grew from USD 7.60 billion in 2024 to USD 8.04 billion in 2025. It is expected to continue expanding at a CAGR of 5.65%, with forecasts placing the market at USD 10.57 billion by 2030. Market growth is attributed to an aging population, increasing disease prevalence, and ongoing adoption of novel diagnostic and therapeutic tools across global regions.

Scope & Segmentation

This report provides a thorough analysis of the glaucoma market, focusing on product development, access strategies, and emerging technologies. Segmentation ensures decision-makers understand the breadth of commercial opportunities and tailored pathways available:

  • Product Categories: Diagnostic and monitoring devices; surgical solutions; a range of therapeutic classes such as prostaglandin analogues, beta blockers, Rho kinase inhibitors, miotics, and combination drugs.
  • End User Environments: Ambulatory surgery centers; home care; hospitals; ophthalmic clinics—each with specific workflow integration and clinical priorities.
  • Distribution Channels: Hospital pharmacies; online pharmacy platforms; retail pharmacy settings to support broad access and supply resilience.
  • Routes of Administration: Intravenous, oral, topical—each route influencing treatment selection and patient adherence.
  • Key Geographic Regions: Americas; Europe, Middle East & Africa; Asia-Pacific. The report highlights regional nuances such as local policy, reimbursement frameworks, and healthcare infrastructure shaping product launch and adoption strategies.
  • Prominent Companies: Novartis AG, AbbVie Inc., Alcon Inc., Pfizer Inc., Merck & Co., Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., Laboratoires Théa SAS, Sun Pharmaceutical Industries Ltd., Glaukos Corporation.

Key Takeaways: Strategic Insights for Glaucoma Market Leaders

  • Demand is rising for technologies supporting early-stage diagnosis and personalized intervention as disease detection shifts toward proactive care models.
  • Innovation in imaging, including high-resolution and AI-based platforms, is improving clinical decision-making and risk stratification for ophthalmologists.
  • Policy and reimbursement shifts, such as greater emphasis on value-based care and longitudinal outcomes, are influencing procurement and treatment protocols globally.
  • Stakeholder collaboration is strengthening, particularly between device manufacturers, pharmaceutical companies, and technology providers, resulting in integrated care ecosystems and expanded pipelines.
  • Distribution and supply strategies are evolving, with healthcare systems prioritizing local manufacturing and adaptive sourcing due to recent tariff changes in the United States for ophthalmic devices and raw pharmaceutical ingredients.
  • Educational initiatives targeting clinicians and care coordinators are supporting faster adoption of best-practice clinical algorithms—enhancing both adherence and patient satisfaction.

Tariff Impact on Devices and Therapeutics

United States tariff adjustments in 2025 have led to increased costs for imported diagnostic instruments, surgical devices, and active pharmaceutical ingredients. Hospitals and providers are reassessing capital equipment budgets and procurement cycles, while distributors seek inventory strategies that mitigate volatility. Manufacturers respond by considering local or domestic alternatives, and payers review budgets to balance cost containment with care quality.

Methodology & Data Sources

The research approach utilizes primary interviews with leading clinicians, procurement experts, and industry stakeholders, complemented by secondary analysis of scientific literature, regulatory guidelines, and validated market data. Quantitative findings are triangulated across regional registries, pharmaceutical sales records, and expenditure reports. Competitive and scenario-based analysis sharpens insight into evolving market dynamics.

Why This Report Matters

  • Strategic stakeholders gain actionable intelligence on emerging growth areas, risk mitigation, and supply chain optimization within the glaucoma sector.
  • Comprehensive product, technology, and regional coverage supports focused investment, localization, and partnership decisions aligned with evolving industry needs.
  • The report enables senior executives to anticipate regulatory and reimbursement changes, strengthening resilience and driving value-based care delivery.

Conclusion

Continuous innovation, adaptive sourcing, and stakeholder collaboration are shaping the next phase of glaucoma market evolution. Access to timely, data-driven insights enables organizations to strengthen competitive positioning while addressing patient-centered care priorities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of micro-invasive glaucoma surgery procedures across ophthalmology practices
5.2. Increasing use of sustained-release intraocular drug delivery implants to improve patient adherence
5.3. Integration of artificial intelligence and deep learning in glaucoma diagnosis and progression monitoring
5.4. Expansion of teleophthalmology platforms for remote glaucoma care and patient monitoring
5.5. Development of novel gene therapies targeting retinal ganglion cell protection in glaucoma management
5.6. Rising competition from generic prostaglandin analogs impacting branded glaucoma medication revenues
5.7. Implementation of 24-hour home tonometry devices for comprehensive intraocular pressure profiling
5.8. Market entry of multi-mechanistic combination eye drops to enhance efficacy and reduce dosing frequency
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Glaucoma Market, by Product Type
8.1. Introduction
8.2. Diagnostic & Monitoring Devices
8.2.1. Fundus Cameras
8.2.2. Optical Coherence Tomography
8.2.3. Pachymeters
8.2.4. Perimetry Devices
8.2.5. Tonometry Devices
8.3. Surgical Devices
8.3.1. Glaucoma Drainage Implants
8.3.2. Laser Devices
8.3.3. Micro-Invasive Glaucoma Surgery Devices
8.3.3.1. Hydrus
8.3.3.2. IStent
8.3.3.3. Xen Gel Stent
8.3.4. Trabeculectomy Devices
8.4. Therapeutics
8.4.1. Alpha Agonists
8.4.2. Beta Blockers
8.4.3. Carbonic Anhydrase Inhibitors
8.4.4. Combination Drugs
8.4.5. Miotics
8.4.6. Prostaglandin Analogues
8.4.7. Rho Kinase Inhibitors
9. Glaucoma Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Home Care Settings
9.4. Hospitals
9.5. Ophthalmic Clinics
10. Glaucoma Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Glaucoma Market, by Route Of Administration
11.1. Introduction
11.2. Intravenous
11.3. Oral
11.4. Topical
12. Americas Glaucoma Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Glaucoma Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Glaucoma Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Novartis AG
15.3.2. AbbVie Inc.
15.3.3. Alcon Inc.
15.3.4. Pfizer Inc.
15.3.5. Merck & Co., Inc.
15.3.6. Bausch Health Companies Inc.
15.3.7. Santen Pharmaceutical Co., Ltd.
15.3.8. Laboratoires Théa SAS
15.3.9. Sun Pharmaceutical Industries Ltd.
15.3.10. Glaukos Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GLAUCOMA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GLAUCOMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GLAUCOMA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLAUCOMA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GLAUCOMA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GLAUCOMA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES GLAUCOMA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLAUCOMA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. GLAUCOMA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. GLAUCOMA MARKET: RESEARCHAI
FIGURE 24. GLAUCOMA MARKET: RESEARCHSTATISTICS
FIGURE 25. GLAUCOMA MARKET: RESEARCHCONTACTS
FIGURE 26. GLAUCOMA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GLAUCOMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GLAUCOMA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GLAUCOMA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GLAUCOMA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GLAUCOMA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GLAUCOMA MARKET SIZE, BY FUNDUS CAMERAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GLAUCOMA MARKET SIZE, BY FUNDUS CAMERAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GLAUCOMA MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GLAUCOMA MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GLAUCOMA MARKET SIZE, BY PACHYMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GLAUCOMA MARKET SIZE, BY PACHYMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GLAUCOMA MARKET SIZE, BY PERIMETRY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GLAUCOMA MARKET SIZE, BY PERIMETRY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GLAUCOMA MARKET SIZE, BY TONOMETRY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GLAUCOMA MARKET SIZE, BY TONOMETRY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GLAUCOMA MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GLAUCOMA MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GLAUCOMA MARKET SIZE, BY LASER DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GLAUCOMA MARKET SIZE, BY LASER DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GLAUCOMA MARKET SIZE, BY HYDRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GLAUCOMA MARKET SIZE, BY HYDRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GLAUCOMA MARKET SIZE, BY ISTENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GLAUCOMA MARKET SIZE, BY ISTENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GLAUCOMA MARKET SIZE, BY XEN GEL STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GLAUCOMA MARKET SIZE, BY XEN GEL STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GLAUCOMA MARKET SIZE, BY TRABECULECTOMY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GLAUCOMA MARKET SIZE, BY TRABECULECTOMY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GLAUCOMA MARKET SIZE, BY ALPHA AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GLAUCOMA MARKET SIZE, BY ALPHA AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GLAUCOMA MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GLAUCOMA MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GLAUCOMA MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GLAUCOMA MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GLAUCOMA MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GLAUCOMA MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GLAUCOMA MARKET SIZE, BY MIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GLAUCOMA MARKET SIZE, BY MIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GLAUCOMA MARKET SIZE, BY PROSTAGLANDIN ANALOGUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GLAUCOMA MARKET SIZE, BY PROSTAGLANDIN ANALOGUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GLAUCOMA MARKET SIZE, BY RHO KINASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GLAUCOMA MARKET SIZE, BY RHO KINASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GLAUCOMA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GLAUCOMA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GLAUCOMA MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GLAUCOMA MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GLAUCOMA MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GLAUCOMA MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GLAUCOMA MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GLAUCOMA MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GLAUCOMA MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GLAUCOMA MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GLAUCOMA MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GLAUCOMA MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GLAUCOMA MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GLAUCOMA MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GLAUCOMA MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GLAUCOMA MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS GLAUCOMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES GLAUCOMA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES GLAUCOMA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 125. CANADA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 128. CANADA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 129. CANADA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 130. CANADA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 131. CANADA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 132. CANADA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 133. CANADA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 134. CANADA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 135. CANADA GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. CANADA GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. CANADA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. CANADA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. CANADA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 144. MEXICO GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 145. MEXICO GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 146. MEXICO GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 147. MEXICO GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 148. MEXICO GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 149. MEXICO GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. MEXICO GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. MEXICO GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. GERMANY GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 226. GERMANY GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 227. GERMANY GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 228. GERMANY GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 229. GERMANY GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 230. GERMANY GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 231. GERMANY GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 232. GERMANY GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 233. GERMANY GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. GERMANY GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. GERMANY GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. GERMANY GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. GERMANY GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. GERMANY GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. FRANCE GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. FRANCE GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. FRANCE GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 242. FRANCE GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 243. FRANCE GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 244. FRANCE GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 245. FRANCE GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 246. FRANCE GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 247. FRANCE GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 248. FRANCE GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 249. FRANCE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. FRANCE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. FRANCE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. FRANCE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. FRANCE GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. FRANCE GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. ITALY GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. ITALY GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. ITALY GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 274. ITALY GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 275. ITALY GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 276. ITALY GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 277. ITALY GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 278. ITALY GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 279. ITALY GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 280. ITALY GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 281. ITALY GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. ITALY GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. ITALY GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. ITALY GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. ITALY GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. ITALY GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. SPAIN GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. SPAIN GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. SPAIN GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 290. SPAIN GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 291. SPAIN GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 292. SPAIN GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 293. SPAIN GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 294. SPAIN GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 295. SPAIN GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 296. SPAIN GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 297. SPAIN GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. SPAIN GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SPAIN GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. SPAIN GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. SPAIN GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. SPAIN GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 322. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 324. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 326. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 328. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 334. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 338. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 339. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 340. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 341. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2024 (USD MILLION)
TABLE 342. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2025-2030 (USD MILLION)
TABLE 343. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 344. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 345. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 348. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 349. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 350. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 351. DENMARK GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 352. DENMARK GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 353. DENMARK GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 354. DENMARK GLAUCOMA MARKET SIZ

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Glaucoma market report include:
  • Novartis AG
  • AbbVie Inc.
  • Alcon Inc.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Bausch Health Companies Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Laboratoires Théa SAS
  • Sun Pharmaceutical Industries Ltd.
  • Glaukos Corporation

Table Information